Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Immunex completes BLA submission for Enbrel

May 8, 1998

Hydroxamic and carboxylic acid derivatives as inhibitors of MMPs and TNF production

May 8, 1998

Patient enrollment complete for phase III trial of GL-701 in SLE

May 6, 1998

Taisho prepares new cytokine inhibitors for inflammatory, allergic and other disorders

May 5, 1998

Bindarit development redirected toward SLE indication

May 5, 1998

Taisho scientists isolate cell adhesion inhibitors for arthritis, inflammation and asthma

May 1, 1998

Connetics and Suntory sign agreement for scleroderma treatment

April 29, 1998

Merck presents clinical data on COX-2 inhibitor at FASEB 98

April 28, 1998

New findings support the hypothesis that fetal cells are involved in scleroderma

April 28, 1998

Dupuytren's disease treatment shows promise in early clinical trials

April 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...